Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518040 | SCV000614851 | uncertain significance | not specified | 2017-02-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314903 | SCV000848191 | likely benign | Inborn genetic diseases | 2018-07-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001637062 | SCV001849195 | benign | not provided | 2020-01-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001637062 | SCV002410119 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003915458 | SCV004733177 | likely benign | RAI1-related disorder | 2020-04-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |